Skip to main content
. Author manuscript; available in PMC: 2020 Jul 13.
Published in final edited form as: Mol Pharm. 2019 Jan 16;16(2):552–560. doi: 10.1021/acs.molpharmaceut.8b00836

Table 2.

Median Survival of ES-2-luc-Bearing Xenograft Mice

formulation empty disc disc with paclitaxel and rapamycin sol—gel with paclitaxel and rapamycin empty sol—gel control (no surgery and no treatment)
mean survival (days) 21 30 36 21 21